Pollandt Sebastian, Liu Jie, Orozco-Cabal Luis, Grigoriadis Dimitri E, Vale Wylie W, Gallagher Joel P, Shinnick-Gallagher Patricia
University of Texas Medical Branch, Department of Pharmacology and Toxicology, Galveston, TX 77555-1031, USA.
Eur J Neurosci. 2006 Sep;24(6):1733-43. doi: 10.1111/j.1460-9568.2006.05049.x.
Cocaine addiction is an enduring, relapsing, behavioural disorder in which stressors reinstate cocaine-seeking even after prolonged abstinence. Evidence suggests that the 'anxiety-like' behaviour and stress associated with protracted withdrawal may be mediated by increased corticotropin-releasing factor (CRF) in the central nucleus of the amygdala (CeA), a part of the limbic circuitry engaged in the coding and transmission of stimulus-reward associations. In the present study we describe a long-lasting potentiation of glutamatergic transmission induced at lateral amygdala (LA)-to-CeA synapses by rat/human CRF. After 2 weeks of withdrawal from repeated intermittent exposure to cocaine, CRF-induced long-term potentiation (LTP) was greatly enhanced compared to the respective saline control group while, after short-term withdrawal (24 h), there was no significant difference between the two treatment groups, indicating alterations in CRF systems during protracted withdrawal from chronic cocaine. After prolonged withdrawal, CRF-induced LTP was dependent on activation of CRF2, CaV2.3 (R-type) calcium channels and intracellular signalling through protein kinase C in both saline- and cocaine-treated groups. The enhanced CRF-induced LTP after 2 weeks of withdrawal was mediated through augmented CRF1 receptor function, associated with an increased signalling through protein kinase A, and required N-methyl-D-aspartate (NMDA) receptors. Accordingly, single-cell recordings revealed a significantly increased NMDA/AMPA ratio after prolonged withdrawal from the cocaine treatment. These results support a role for CRF1 receptor antagonists as plausible treatment options during withdrawal from chronic cocaine and suggest Ca(V)2.3 blockers as potential candidates for pharmaceutical modulation of CRF systems.
可卡因成瘾是一种持久的、复发性的行为障碍,即使在长期禁欲后,应激源也会恢复对可卡因的寻求行为。有证据表明,与长期戒断相关的“焦虑样”行为和应激可能由杏仁核中央核(CeA)中促肾上腺皮质激素释放因子(CRF)的增加介导,CeA是边缘回路的一部分,参与刺激-奖励关联的编码和传递。在本研究中,我们描述了大鼠/人类CRF在外侧杏仁核(LA)至CeA突触处诱导的谷氨酸能传递的长期增强。在反复间歇性接触可卡因后戒断2周,与相应的生理盐水对照组相比,CRF诱导的长期增强(LTP)大大增强,而在短期戒断(24小时)后,两个治疗组之间没有显著差异,这表明在从慢性可卡因长期戒断期间CRF系统发生了改变。长期戒断后,CRF诱导的LTP在生理盐水处理组和可卡因处理组中均依赖于CRF2、CaV2.3(R型)钙通道的激活以及通过蛋白激酶C的细胞内信号传导。戒断2周后增强的CRF诱导的LTP是通过增强的CRF1受体功能介导的,这与通过蛋白激酶A增加的信号传导相关,并且需要N-甲基-D-天冬氨酸(NMDA)受体。因此,单细胞记录显示,在从可卡因治疗中长时间戒断后,NMDA/AMPA比率显著增加。这些结果支持CRF1受体拮抗剂在从慢性可卡因戒断期间作为合理治疗选择的作用,并表明Ca(V)2.3阻滞剂作为CRF系统药物调节的潜在候选者。